Search research articles
Contact Us
Filters
Showing results (41-50 of 88) with videos related to
Page
of 9
Sort By:
ESC Heart Failure
|
March 13, 2020
Prognostic impact of angiographic findings, procedural success, and timing of percutaneous coronary intervention in cardiogenic shock
Tuija Sabell, Marek Banaszewski, Johan Lassus, et al.
International Journal of Molecular Sciences
|
October 29, 2020
Association of miR-21-5p, miR-122-5p, and miR-320a-3p with 90-Day Mortality in Cardiogenic Shock
Mikko Hänninen, Toni Jäntti, Heli Tolppanen, et al.
Critical Care Medicine
|
April 14, 2017
Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome
Heli Tolppanen, Mercedes Rivas-Lasarte, Johan Lassus, et al.
Critical Care (London, England)
|
July 5, 2016
Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality
Tuukka Tarvasmäki, Johan Lassus, Marjut Varpula, et al.
European Journal of Heart Failure
|
September 22, 2018
Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial
Wilfried Mullens, Frederik H Verbrugge, Petra Nijst, et al.
Journal of the American College of Cardiology
|
May 17, 2023
Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload
Frederik H Verbrugge, Pieter Martens, Jeroen Dauw, et al.
International Journal of Cardiology
|
January 4, 2017
Use of noninvasive and invasive mechanical ventilation in cardiogenic shock: A prospective multicenter study
Mari Hongisto, Johan Lassus, Tuukka Tarvasmaki, et al.
ESC Heart Failure
|
February 3, 2025
Validation of a biomarker-based mortality score for cardiogenic shock patients: Comparison with a clinical risk score
Elina Hynninen, Heli Tolppanen, Mercedes Rivas-Lasarte, et al.
Circulation. Heart Failure
|
August 22, 2024
Serum Chloride and the Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload: A Post Hoc Analysis From the ADVOR Trial
Jef Van den Eynde, Pieter Martens, Jeroen Dauw, et al.
The American Journal of Cardiology
|
August 20, 2017
Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic Shock
Toni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 88) with videos related to
Sort By:
Page
of 9
ESC Heart Failure
|
March 13, 2020
Prognostic impact of angiographic findings, procedural success, and timing of percutaneous coronary intervention in cardiogenic shock
Tuija Sabell, Marek Banaszewski, Johan Lassus, et al.
International Journal of Molecular Sciences
|
October 29, 2020
Association of miR-21-5p, miR-122-5p, and miR-320a-3p with 90-Day Mortality in Cardiogenic Shock
Mikko Hänninen, Toni Jäntti, Heli Tolppanen, et al.
Critical Care Medicine
|
April 14, 2017
Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome
Heli Tolppanen, Mercedes Rivas-Lasarte, Johan Lassus, et al.
Critical Care (London, England)
|
July 5, 2016
Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality
Tuukka Tarvasmäki, Johan Lassus, Marjut Varpula, et al.
European Journal of Heart Failure
|
September 22, 2018
Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial
Wilfried Mullens, Frederik H Verbrugge, Petra Nijst, et al.
Journal of the American College of Cardiology
|
May 17, 2023
Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload
Frederik H Verbrugge, Pieter Martens, Jeroen Dauw, et al.
International Journal of Cardiology
|
January 4, 2017
Use of noninvasive and invasive mechanical ventilation in cardiogenic shock: A prospective multicenter study
Mari Hongisto, Johan Lassus, Tuukka Tarvasmaki, et al.
ESC Heart Failure
|
February 3, 2025
Validation of a biomarker-based mortality score for cardiogenic shock patients: Comparison with a clinical risk score
Elina Hynninen, Heli Tolppanen, Mercedes Rivas-Lasarte, et al.
Circulation. Heart Failure
|
August 22, 2024
Serum Chloride and the Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload: A Post Hoc Analysis From the ADVOR Trial
Jef Van den Eynde, Pieter Martens, Jeroen Dauw, et al.
The American Journal of Cardiology
|
August 20, 2017
Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic Shock
Toni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola, et al.
Page
of 9